Ares Management Reports Q3 Results as Stock Recovers from a Bruising Year

ARES reports Q3 results on October 30 after a week in which the stock added 3% to close at $127.47, erasing some of a year-to-date decline that had reached nearly 28%. The recovery brings the stock within 14% of the analyst consensus price target of $144.70, a gap that frames Thursday's print as a significant test of whether Q1's earnings miss was a one-off stumble or the start of a more persistent trend.

Positioning in the lending market gives bears little ammunition. Availability sits at 280%, meaning roughly three shares remain available to borrow for every one already lent out, well above the 52-week tightest reading of 209%. The cost to borrow has edged up 5% on the week to 0.51% but remains historically low, and short interest at 7.3% of free float has drifted sideways over the past month after falling from mid-September peaks near 16.2 million shares. The ORTEX short score of 59.5 is moderate and has held in a narrow range for the past two weeks, suggesting no fresh wave of conviction from bears. Options are a different signal: the put/call ratio of 2.50 is running above its 20-day average of 2.45, though only about one standard deviation elevated, pointing to mild caution rather than outright alarm.

The analyst community has been trimming targets into this print without abandoning the core positive view. BMO Capital lowered its target from $134 to $130 on October 27, maintaining a Market Perform rating. Piper Sandler and UBS both cut targets earlier in October while keeping their ratings unchanged. The direction of travel is clear: the Street sees less upside than it did a quarter ago, but has not moved to the sidelines en masse. TD Cowen and JP Morgan still carry Buy and Overweight ratings respectively, and Oppenheimer lifted its target as recently as August. The bull case rests on Ares's scale, $671.3 billion of total AUM, its diversified platform across credit, real estate and private equity, and management's stated 16% to 20% FRE compound growth target through 2028. The bear case is rooted in Q1's specific miss: after-tax realized net income came in at $1.24 per share against an estimate of $1.37, and FRE of $1.33 per share fell short of the $1.43 expected, driven by shortfalls in both fee-related performance fees and base management fees that better-than-expected cost control could not offset.

The Q3 print will test whether the Q1 fee weakness was seasonal or structural, and whether the firm's deployment activity in credit and real assets has translated into the fee-earning AUM growth the margin expansion thesis depends on.